264 results about "Tissue penetration" patented technology

A biopsy system having a lateral tissue access port includes an energy based tissue penetration system that can advantageously penetrate hard tumors, improve hemostasis, and provide greater tissue access. The energy based tissue penetration system has a vibrational member removeably disposed within the biopsy system, and a distal tip of the vibrational member extending from the biopsy system for tissue penetration. A sleeve is located between the vibrational member and the lateral access port to prevent tissue contact with the vibrational member through the lateral access port.

A body fluid sampling system is provided for use on a tissue site. A drive force generator is coupled to penetrating members. The penetrating members are at least partially housed in a penetrating member housing. The penetrating member housing has openings for the penetrating members. The penetrating members are launched along a launch path by the drive force generator through an opening in the penetrating member housing. Analyte sensors are housed in a analyte sensor housing. Each analyte sensor is associated with a penetrating member. The analyte sensor housing and the penetrating member housing are coupled to provide that each analyte sensor is positioned out of a launch path of a penetrating member. The analyte sensor housing includes desiccant pockets for receiving desiccant plugs

Devices, systems, and methods treat cosmetic defects, and often apply cooling with at least one tissue-penetrating probe inserted through of the skin of a patient. The cooling may remodel one or more target tissue so as to effect a desired change in a composition of the target tissue and/or a change in its behavior. Exemplary embodiments of the cooling treatments will interfere with the nerve/muscle contractile function chain so as to mitigate wrinkles of the skin. Related treatments may be used therapeutically for treatment of back and other muscle spasms, chronic pain, and the like. Some embodiments may remodel subcutaneous adipose tissue so as to alter a shape or appearance of the skin surface.

Devices, systems, and methods treat cosmetic defects, and often apply cooling with at least one tissue-penetrating probe inserted through of the skin of a patient. The cooling may remodel one or more target tissue so as to effect a desired change in a composition of the target tissue and/or a change in its behavior. Exemplary embodiments of the cooling treatments will interfere with the nerve/muscle contractile function chain so as to mitigate wrinkles of the skin. Related treatments may be used therapeutically for treatment of back and other muscle spasms, chronic pain, and the like. Some embodiments may remodel subcutaneous adipose tissue so as to alter a shape or appearance of the skin surface.

A system for securing an implantable apparatus to a mammal includes a mount including a base portion having a plurality of holes dimensioned to receive rotationally-driven fasteners, each fastener comprising a helical portion having a tip configured for tissue penetration, the mount configured to secure the implantable apparatus relative to tissue of the mammal upon driving the fasteners into the tissue. The system further includes a fastening tool configured to rotationally drive the helical portion of the fasteners into the tissue. The mount may be secured to the fascia covering the sternum via a subcutaneous securement method, or it may be attached to the intra-abdominal wall, behind the sternum, or it may be attached to the sternum directly via bone screws or the like.

A laser can produce pulses of light energy to eject a volume of the tissue, and the energy can be delivered to a treatment site through a waveguide, such as a fiber optic waveguide. The incident laser energy can be absorbed within a volume of the target tissue with a tissue penetration depth and pulse direction such that the propagation of the energy from the tissue volume is inhibited and such that the target tissue within the volume reaches the spinodal threshold of decomposition and ejects the volume, for example without substantial damage to tissue adjacent the ejected volume.

A body fluid sampling system for use on a tissue site includes a drive force generator. A plurality of penetrating members are housed in a penetrating member housing. Each of penetrating member is configured to be coupled to the drive force generator. A plurality of analyte sensors are housed in an analyte sensor housing. Each analyte sensor is associated with a penetrating member. The analyte sensor housing is in a surrounding relationship to the penetrating member housing and positioned to provide that upon launch of a penetrating member, and penetration of a penetrating member at a skin surface, blood flows into the analyte sensor.

A tissue penetrating system has a housing member, a plurality of penetrating members positioned in the housing member and a plurality of sample chambers. Each sample chamber is associated with a penetrating member. A tissue stabilizing member has a tissue interface surface configured to be applied to a tissue surface and provide for spontaneous flow of blood for sample capture. The tissue stabilizing member is coupled to the housing.

Methods and devices are provided for delivering a drug to or withdrawing a fluid from a biological tissue, such the skin, sclera, cornea, and conjunctiva. One method includes the steps of inserting at least one microneedle into the biological tissue; partially retracting the at least one microneedle from the tissue; and then delivering at least one drug formulation into the biological tissue via the partially retracted at least one microneedle. The microneedle deforms and penetrates the biological tissue during the insertion step, and the retraction step at least partially relaxes the tissue deformation while maintaining at least part of the tissue penetration, facilitating drug delivery or fluid withdrawal.

Non-hydroxyalkylated cyclodextrins are disclosed wherein at least one primary alcohol function (CH2OH) is substituted, the -OH portion being replaced by a substituent with formula -O-CO-R or -NR1R2, where:R, R1 and R2 independently represent a linear or cyclic, saturated or unsaturated, hydroxylated or non-hydroxylated alkyl group containing 1 to 30 carbon atoms, preferably 1 to 22 carbon atoms, more preferably a fatty chain containing 2 to 22 carbon atoms. These cyclodextrins are used as vectors for at least one active ingredient, in particular to encourage tissue penetration, in a cosmetic application, or for the production of pharmaceutical compositions, in particular dermopharmaceuticals.

Various methods and devices are provided for penetrating tissue. In one embodiment, a tissue-penetrating device is provided and includes a flexible hollow elongate shaft having a tissue-penetrating tip at a distal end thereof, and a plunger disposed within the tissue-penetrating tip. The plunger can be movable relative to the tissue-penetrating tip between a distal position in which the plunger is distal of the tissue-penetrating tip to prevent tissue penetration, and a proximal position in which the plunger is proximal of the tissue-penetrating tip to allow the tip to penetrate tissue. The plunger can be adapted to move from the distal position to the proximal position when the plunger is advanced into a tissue surface. The device can also include a biasing element coupled to the plunger that can be adapted to bias the plunger to the distal position. The biasing element can be coupled between a distal end of a stylet that extends through the hollow elongate shaft, and a proximal end of the plunger.

A tissue penetrating catheter that is usable to advance a tissue penetrator from within a blood vessel, through the wall of the blood vessel to a target location. The catheter includes at least one stabilizing device thereon for stabilizing catheter prior to advancing the tissue penetrator. The tissue penetrator may extend through a lumen in the body of the catheter and project transversely through an exit port. The stabilizing device may be located closely adjacent to the exit port, or may surround the exit port. The stabilizing device may be one or more balloons, or other mechanical structure that is expandable into contact with the inner luminal wall of the blood vessel. Desirably, the exit port is forced into contact with the blood vessel wall to shorten the distance that the tissue penetrator projects from the catheter body to the target location. The catheter is particular useful for forming blood flow tracts between blood vessels, in particular in coronary revascularization procedures. Methods of utilizing such a catheter to bypass an arterial obstruction is also disclosed.

Devices and methods are disclosed for providing a sensing element to scan tissue and detect the presence of structures within the tissue to avoid the structures when performing a procedure on the tissue. A tissue penetrating member or needle is extendable from the device to create a channel or opening through the wall of an airway. The device is sufficiently flexible to navigate turns of at least 90 degrees. The distal section of the device includes puncture resistant sections, a curved needle tip, and depth limiting features that serve to create a channel in the lumen wall without causing collateral damage to the instruments, or patient.

Devices and methods are provided for penetrating tissue and/or effecting movement of devices relative to tissue. In general, a surgical instrument is provided having an at least partially fabric-covered distal tip that be used to at least partially penetrate tissue by contacting the tissue with the fabric and rotating the fabric to “drill” into the tissue. The surgical instrument can be configured for delivery proximate to tissue through a working channel of a delivery device and can include an elongate shaft having in its distal portion an end effector at least partially covered in fabric. The fabric, the end effector, and/or the shaft can rotate, thereby allowing at least the fabric to penetrate the tissue and, if sufficiently rotated, causing an opening to form in the tissue. The surgical instrument and/or the delivery device can be advanced through the opening.

Suture passers for suturing tissue in a continuous manner by passing a suture attached to a suture shuttle through. A suture passer may include a first jaw, a second jaw, and a tissue penetrator that is retractable and extendable from the first jaw. The tissue penetrator may have a suture shuttle engagement region, and the second jaw may include a shuttle dock. The suture shuttle may be transferred between the first and second jaws as the tissue penetrator is extended from the first jaw and engages the second jaw. In some variations of the tissue passer, one or both jaws are tissue penetrating. In some variations, the jaws open in parallel, allowing large tissue regions to be positioned between the jaws. Methods of using these devices are also described, as are systems and kits including these devices.

A medical device for crossing a tissue wall and methods of use thereof are provided. The device may include a flexible shaft defining a proximal portion, a distal portion, and a lumen extending therebetween to apply a vacuum to at least a portion of the tissue wall; and a tissue penetration element movably positioned within the shaft. The device may further include one or more anchors, one or more expandable elements disposed thereon, an image capture device coupled to a portion thereof, an expandable array, and/or one or more electrically conductive segments.

The instant invention is directed toward a method and an apparatus for mapping the magnetic field strength or flux density of a magnetic source. The invention provides a robotically controlled sensor which is moved in a controlled manner throughout an area of flux density and the variations in the flux density are recorded. The position and recorded magnetic field strength at numerous points throughout the test area are recorded and the data is assembled into a graphical representation the end result of which is a multi-dimensional mapping of the magnetic field strength as a function of distance from the source. The testing method and apparatus provide a convenient methodology for accurately determining dosimetry and tissue penetration of therapeutic magnetic devices.

A tissue penetration device is provided that includes a bell-like, at least partially transparent housing. A valved port is provided in the housing for introduction of a penetrator therein. The valved port includes both a valve control and a port. A vacuum system, including a vacuum source, is securely and sealably attached through the housing to advance a patient's tissue onto the penetrator.